Tonix Pharmaceuticals Says World Health Organization's Preferred Target Product Profile, Aligns With The Characteristics Of TNX-801 (Horsepox, Live Virus) Vaccine, Which Is Being Developed For Preventing Mpox
Tonix Pharmaceuticals Says World Health Organization's Preferred Target Product Profile, Aligns With The Characteristics Of TNX-801 (Horsepox, Live Virus) Vaccine, Which Is Being Developed For Preventing Mpox
tonix pharmaceuticals表示，世界衛生組織的首選目標產品概述與開發用於預防天花的TNX-801（馬痘，活性病毒）疫苗的特點相一致
Tonix Pharmaceuticals Says World Health Organization's Preferred Target Product Profile, Aligns With The Characteristics Of TNX-801 (Horsepox, Live Virus) Vaccine, Which Is Being Developed For Preventing Mpox
tonix pharmaceuticals表示，世界衛生組織的首選目標產品概述與開發用於預防天花的TNX-801（馬痘，活性病毒）疫苗的特點相一致
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間